| Positron emission tomography in cancer of the head and neck. | |
| | |
MedLine Citation:
|
PMID: 15620766 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The use of positron emission tomography (PET) has increased in oncology and in the assessment of head and neck tumours, where it is most useful for recurrent disease. It has good sensitivity and specificity for diagnosis and staging but is generally not necessary except in difficult cases. Quantitative measures of uptake on PET at diagnosis and after treatment do seem to have prognostic value independent of other information about the tumour and so PET may influence management. It also has a role in the identification of an unknown primary site and of synchronous primaries and metastases (often missed by other imaging). Fusion imaging with magnetic resonance (MRI) or computed tomography (CT) adds a new dimension with improved value for each technique. |
| | |
Authors:
|
Sharon F Hain |
Related Documents
:
|
8565886 - Endoscopic mri: preliminary results of a new technique for visualization and staging of... 15827416 - Pet/ct imaging of metastatic deposit in vertebral paget's disease. 9137966 - Imaging and medical staging of lung cancer. 19581636 - Positron emission tomography in staging early lung cancer: a randomized trial. 21897306 - Tc-99m methoxyisobutylisonitrile parathyroid scintigraphy: the value of adding a whole-... 1955286 - Mri in patients with amyotrophic lateral sclerosis: correlation with clinical features. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The British journal of oral & maxillofacial surgery Volume: 43 ISSN: 0266-4356 ISO Abbreviation: Br J Oral Maxillofac Surg Publication Date: 2005 Feb |
Date Detail:
|
Created Date: 2004-12-28 Completed Date: 2005-03-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8405235 Medline TA: Br J Oral Maxillofac Surg Country: Scotland |
Other Details:
|
Languages: eng Pagination: 1-6 Citation Subset: D; IM |
Affiliation:
|
The Institute of Nuclear Medicine, Middlesex Hospital, UCH NHS Trust and Charing Cross Hospital, Hammersmith Hospitals NHS Trust, London W1T 3AA, UK. s.hain@nucmed.ucl.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma, Squamous Cell
/
radionuclide imaging* Fluorodeoxyglucose F18 / diagnostic use Head and Neck Neoplasms / radionuclide imaging* Humans Lymph Nodes / radionuclide imaging Neoplasm Metastasis / radionuclide imaging Neoplasm Recurrence, Local / radionuclide imaging Neoplasms, Second Primary / radionuclide imaging Positron-Emission Tomography* Prognosis Radiopharmaceuticals / diagnostic use Sensitivity and Specificity |
| Chemical | |
Reg. No./Substance:
|
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A comparison of predicted and measured levels of runoff-related pesticide concentrations in small lo...
Next Document: A randomised controlled clinical trial to compare the incidence of injury to the inferior alveolar n...